Liver-selective γ-secretase inhibition ameliorates diet-induced hepatic steatosis, dyslipidemia and atherosclerosis
- 18 May 2020
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 527 (4) , 979-984
Abstract
No abstract availableKeywords
Funding Information
- American Heart Association
- National Research Foundation of Korea
- Inha University
- Columbia University
- National Institutes of Health
This publication has 42 references indexed in Scilit:
- Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent mannerNature Medicine, 2011
- Biological, clinical and population relevance of 95 loci for blood lipidsNature, 2010
- γ-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemiaNature Medicine, 2008
- Title pageThe American Journal of Cardiology, 2008
- The Residual Risk Reduction Initiative: A Call to Action to Reduce Residual Vascular Risk in Patients with DyslipidemiaThe American Journal of Cardiology, 2008
- Proteomic Profiling of γ-Secretase Substrates and Mapping of Substrate RequirementsPLOS Biology, 2008
- Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control studyThe Lancet, 2004
- Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein EScience, 1992
- Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cellsCell, 1992
- How LDL Receptors Influence Cholesterol and AtherosclerosisScientific American, 1984